Cellectis

(NASDAQ) CLLS

Current Price$3.84

Market Cap$279.18M

Since IPO (2015)-90%

5 Year-76%

1 Year+153%

1 Month+15%

Cellectis Financials at a Glance

Market Cap

$279.18M

Revenue (TTM)

$72.95M

Net Income (TTM)

$67.57M

EPS (TTM)

$-0.68

P/E Ratio

-5.70

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$3.84

Volume

12,659

Open

$3.90

Price

$3.84

Volume

12,659

Open

$3.90

Previous Close

$3.86

Daily Range

$3.74 - $4.00

52-Week Range

$1.33 - $5.48

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$3.84

Volume

12,659

Open

$3.90

Previous Close

$3.86

Daily Range

$3.74 - $4.00

52-Week Range

$1.33 - $5.48

CLLS News

Page 1

CLLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cellectis

Industry

Biotechnology

Sector

Health Care

Employees

229

CEO

André Choulika, PhD

Website

www.cellectis.com

Headquarters

Paris, 75013, FR

CLLS Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

-48%

Net Income Margin

-93%

Return on Equity

-66%

Return on Capital

-19%

Return on Assets

-21%

Earnings Yield

-17.54%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$279.18M

Shares Outstanding

72.33M

Volume

12.66K

Avg. Volume

39.72K

Financials (TTM)

Gross Profit

$53.05M

Operating Income

$40.48M

EBITDA

$20.36M

Operating Cash Flow

$40.14M

Capital Expenditure

$2.37M

Free Cash Flow

$42.50M

Cash & ST Invst.

$208.66M

Total Debt

$119.90M

Cellectis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$10.40M

-18.3%

Gross Profit

$7.40M

-27.5%

Gross Margin

71.15%

N/A

Market Cap

$279.18M

N/A

Market Cap/Employee

$1.29M

N/A

Employees

216

N/A

Net Income

$26.30M

-544.1%

EBITDA

$19.61M

-238.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$88.76M

-47.4%

Accounts Receivable

$22.20M

-3.6%

Inventory

$0.00

N/A

Long Term Debt

$101.74M

+30.0%

Short Term Debt

$18.16M

+37.3%

Return on Assets

-20.89%

N/A

Return on Invested Capital

-19.41%

N/A

Free Cash Flow

$10.95M

-511.2%

Operating Cash Flow

$10.47M

-22183.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.92-1.68%

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$14.84-0.40%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$6.95-5.57%

LRMRLarimar Therapeutics, Inc.

LRMRLarimar Therapeutics, Inc.$4.00-3.61%

KRROKorro Bio, Inc.

KRROKorro Bio, Inc.$12.89-3.37%

ALDXAldeyra Therapeutics, Inc.

ALDXAldeyra Therapeutics, Inc.$1.73-0.57%

DBVTDBV Technologies S.A.

DBVTDBV Technologies S.A.$19.99-0.55%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.35-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

IRENIren

IRENIren$56.85-0.07%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

Questions About CLLS

What is the current price of Cellectis?

Cellectis is trading at $3.86 per share.

What is the 52-week range for Cellectis?

Over the past 52 weeks, Cellectis has traded between $1.33 and $5.48.

How much debt does Cellectis have?

As of the most recent reporting period, Cellectis reported total debt of $119.90M.

How much cash does Cellectis have on hand?

Cellectis reported $63.58M in cash and cash equivalents in its most recent financial results.

What is Cellectis’s dividend yield?

Cellectis does not currently have a dividend yield.

Cellectis

Cellectis Financials at a Glance

CLLS News

Why Cellectis' Shares Rose 22.7% This Week

Why Cellectis Stock Rose 20.7% This Week

These Gene-Editing Pioneers Are Making Bold Bets in Agriculture

Did Cellectis Just Provide a Glimpse of the Future of Cellular Medicine?

Is Cellectis SA Stock a Buy Now?

Can Been-There Biotech Entrepreneur Arie Belldegrun Do It Yet Again?

Why Micron Technology, Mechel, and Cellectis Slumped Today

Why Mallinckrodt, Universal Insurance Holdings, and Cellectis Slumped Today

CLLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cellectis

CLLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cellectis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLLS

What is the current price of Cellectis?

What is the 52-week range for Cellectis?

How much debt does Cellectis have?

How much cash does Cellectis have on hand?

What is Cellectis’s dividend yield?

Premium Investing Services